Bioxyne enters Central American markets with pastille supply deal by Steve Jones December 12, 2025December 12, 2025 Breathe Life Sciences (BLS) will supply pastilles to two Central American countries in a deal it […]
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
News in brief: Legalise Cannabis ramps up criticism of Victorian government; MCA launches desktop guide for clinicians; Bioxyne secures A$1.7m for UK GMP facility by Adam Sheldon November 17, 2025November 19, 2025
News in brief: Cann completes NAB settlement; Bioxyne releases GMP-certified MDMA capsules by Adam Sheldon November 11, 2025November 18, 2025
Breathe Life Sciences launches Curaleaf medical inhalation device by Adam Sheldon November 3, 2025November 3, 2025
Record revenue for Bioxyne but cash deficit rises after flower investment by Steve Jones October 30, 2025November 3, 2025
Cannabis executive salaries: who earned what in FY25 by Adam Sheldon October 22, 2025October 22, 2025
News in brief: The Entourage Effect named AFR innovation finalist; Bioxyne lists in Germany; Nimbin to host medical cannabis symposium by Steve Jones October 13, 2025October 15, 2025
‘It’s super exciting’ – Breathe Life Sciences secures ARTG listings for Dr Watson range by Adam Sheldon October 9, 2025October 13, 2025
Trump CBD video sparks US stock rally – and hope among local firms by Adam Sheldon October 1, 2025October 1, 2025
